Clinical Trial Update: Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma [Phase 3]

View source ↗

Summary

This is a Phase 3 trial comparing interferon alfa to no further therapy after surgery in patients with stage II, stage III, or recurrent melanoma; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Melanoma (Skin) | Phase 3 | Status: COMPLETED